| Literature DB >> 14723112 |
Abstract
Dry eye disease diminishes the quality of patients' lives and drives utilization of health care resources. Until recently, all treatments for dry eye have been palliative. A new treatment, cyclosporine A ophthalmic emulsion, addresses the disease's underlying causes. It warrants pharmacoeconomic analysis to determine its place in managed care.Entities:
Mesh：
Substances：
Year: 2003 PMID： 14723112
Source DB: PubMed Journal: Manag Care ISSN： 1062-3388